Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) rose 2.1% during mid-day trading on Thursday . The stock traded as high as $14.26 and last traded at $14.1650. Approximately 1,785 shares were traded during trading, a decline of 41% from the average daily volume of 3,031 shares. The stock had previously closed at $13.87.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group upgraded WuXi AppTec to a “buy” rating in a research report on Thursday. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, WuXi AppTec presently has an average rating of “Buy”.
Check Out Our Latest Stock Report on WUXAY
WuXi AppTec Price Performance
About WuXi AppTec
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Recommended Stories
- Five stocks we like better than WuXi AppTec
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
